Travere Therapeutics, Inc. (TVTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$27.21
Day's range
$29.31

Travere Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANUS HENDERSON GROUP PLC 02/17/2026 10.51 M $401.72 M   -0.83% 11.78%
FMR LLC 02/17/2026 9.62 M $367.50 M   232.32% 10.78%
BLACKROCK, INC. 02/12/2026 7.87 M $300.69 M   -2.85% 8.82%
VANGUARD GROUP INC 01/29/2026 6.31 M $241.08 M   -4.60% 7.07%
STATE STREET CORP 02/13/2026 4.76 M $181.75 M   47.82% 5.33%
PERCEPTIVE ADVISORS LLC 02/17/2026 4.28 M $163.47 M   12.74% 4.79%
MACQUARIE MANAGEMENT HOLDINGS, INC. 02/17/2026 3.77 M $144.19 M   100.00% 4.23%
ARMISTICE CAPITAL, LLC 02/17/2026 3.76 M $143.82 M   -44.02% 4.22%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/17/2026 2.93 M $111.84 M   -17.60% 3.28%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 2.25 M $85.85 M   28.23% 2.52%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/17/2026 2.21 M $84.46 M   2.10% 2.48%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 2.14 M $81.92 M   0.26% 2.40%
GOLDMAN SACHS GROUP INC 03/25/2026 1.87 M $71.38 M   46.65% 2.09%
BANK OF AMERICA CORP /DE/ 02/17/2026 1.85 M $70.70 M   32.27% 2.07%
STEPHENS INVESTMENT MANAGEMENT GROUP LLC 02/05/2026 1.72 M $65.78 M   7.62% 1.93%
EMERALD ADVISERS, LLC 02/09/2026 1.59 M $60.91 M   -25.74% 1.79%
MORGAN STANLEY 02/13/2026 1.42 M $54.10 M   26.75% 1.59%
EVERSEPT PARTNERS, LP 02/17/2026 1.17 M $44.90 M   -17.09% 1.32%
TWO SIGMA INVESTMENTS, LP 02/17/2026 1.16 M $44.20 M   24.52% 1.30%
D. E. SHAW & CO., INC. 02/17/2026 1.09 M $41.82 M   65.03% 1.23%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 1.02 M $38.91 M   100.00% 1.14%
NUVEEN, LLC 02/12/2026 993.61 K $37.97 M   -7.89% 1.11%
EMERALD MUTUAL FUND ADVISERS TRUST 02/09/2026 948.46 K $36.24 M   -21.02% 1.06%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/17/2026 901.40 K $34.44 M   27.41% 1.01%
HUDSON BAY CAPITAL MANAGEMENT LP 02/13/2026 900.30 K $34.40 M   184.63% 1.01%
DEUTSCHE BANK AG\ 02/11/2026 881.68 K $33.69 M   -44.87% 0.99%
FIERA CAPITAL CORP 02/11/2026 874.05 K $33.40 M   100.00% 0.98%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 02/17/2026 867.62 K $33.15 M   -1.82% 0.97%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 808.19 K $30.88 M   -4.73% 0.91%
ENSIGN PEAK ADVISORS, INC 02/12/2026 805.22 K $30.77 M   -5.51% 0.90%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 798.98 K $30.53 M   -33.50% 0.90%
NORTHERN TRUST CORP 02/17/2026 761.47 K $29.10 M   -8.49% 0.85%
TWO SIGMA ADVISERS, LP 02/17/2026 725.50 K $27.72 M   4.13% 0.81%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 718.40 K $27.45 M   70.88% 0.81%
TANG CAPITAL MANAGEMENT LLC 02/17/2026 700.00 K $26.75 M   0.00% 0.78%
CAPTION MANAGEMENT, LLC 02/17/2026 666.40 K $25.46 M   15.82% 0.75%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 665.80 K $25.44 M   17.72% 0.75%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 623.39 K $23.82 M   -27.34% 0.70%
PANAGORA ASSET MANAGEMENT INC 02/13/2026 587.35 K $22.44 M   3.10% 0.66%
LEGAL & GENERAL GROUP PLC 02/09/2026 536.93 K $20.52 M   3.14% 0.60%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 534.61 K $20.78 M   -21.88% 0.60%
ABRDN PLC 01/16/2026 518.36 K $19.81 M   -46.42% 0.58%
KYNAM CAPITAL MANAGEMENT, LP 02/17/2026 517.88 K $19.79 M   -45.47% 0.58%
INVESCO LTD. 02/19/2026 474.08 K $18.11 M   -24.50% 0.53%
CANDRIAM S.C.A. 04/30/2026 468.56 K $17.90 M   -8.61% 0.53%
UBS GROUP AG 01/29/2026 422.62 K $16.15 M   -14.29% 0.47%
ASSENAGON ASSET MANAGEMENT S.A. 01/09/2026 417.74 K $15.96 M   347.48% 0.47%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 406.22 K $15.52 M   -28.98% 0.46%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 394.84 K $15.09 M   397.01% 0.44%
JANE STREET GROUP, LLC 02/12/2026 392.27 K $14.99 M   100.00% 0.44%

Travere Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 348 institutional investors and hedge funds held shares of Travere Therapeutics Inc. The most heavily invested institutionals were:

Stephens Investment Management Group LLC: 1.8 M

EMERALD ADVISERS, LLC: 1.56 M

EMERALD MUTUAL FUND ADVISERS TRUST: 945,033

Nuveen, LLC: 938,569

UBS Group AG: 856,757

abrdn plc: 557,147

114.53% of Travere Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 117.98 M shares in the last 24 months. This purchase volume represents approximately $3.42 B in transactions.